(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/01/17 | 日証協 | 110,519株 | -19.27% | 12,781株 | -76.59% | 124,066株 | -5.9% | 16,300株 | -64.41% |
2020/01/10 | 日証協 | 136,900株 | -58% | 54,600株 | -69.22% | 131,847株 | -56.49% | 45,800株 | +1658.83% |
2019/12/30 | 日証協 | 325,927株 | +117.58% | 177,400株 | +523.35% | 303,050株 | +105.93% | 2,604株 | -98.78% |
2019/12/27 | 日証協 | 149,794株 | -18.85% | 28,459株 | -73.15% | 147,162株 | -11.65% | 212,712株 | +241.98% |
2019/12/20 | 日証協 | 184,594株 | +16.03% | 106,000株 | +29.9% | 166,566株 | +9.46% | 62,200株 | +66.76% |
2019/12/13 | 日証協 | 159,094株 | +10.48% | 81,600株 | +24.77% | 152,166株 | +7.95% | 37,300株 | +49.2% |
2019/12/06 | 日証協 | 144,000株 | +2.2% | 65,400株 | +29.25% | 140,966株 | -2.22% | 25,000株 | -33.69% |
2019/11/29 | 日証協 | 140,900株 | -8.86% | 50,600株 | -37.3% | 144,166株 | +4.19% | 37,700株 | +84.8% |
2019/11/22 | 日証協 | 154,600株 | -36.19% | 80,700株 | +1% | 138,366株 | -24.87% | 20,400株 | +22.16% |
2019/11/15 | 日証協 | 242,300株 | -3.2% | 79,900株 | -4.54% | 184,176株 | -5.97% | 16,700株 | +68.69% |
2019/11/08 | 日証協 | 250,300株 | -5.51% | 83,700株 | -19.29% | 195,876株 | -6.18% | 9,900株 | -48.97% |
2019/11/01 | 日証協 | 264,900株 | -5.83% | 103,700株 | +228.16% | 208,776株 | -4.66% | 19,400株 | +165.75% |
2019/10/25 | 日証協 | 281,300株 | -14.73% | 31,600株 | -57.64% | 218,976株 | -16.41% | 7,300株 | -34.23% |
2019/10/18 | 日証協 | 329,900株 | -4.74% | 74,600株 | +8.75% | 261,976株 | -1.21% | 11,100株 | +226.47% |
2019/10/11 | 日証協 | 346,300株 | -6.76% | 68,600株 | +218.73% | 265,176株 | -7.76% | 3,400株 | -41.47% |
2019/10/04 | 日証協 | 371,400株 | -11.65% | 21,523株 | -73.19% | 287,482株 | -7.91% | 5,809株 | -56.92% |
2019/09/27 | 日証協 | 420,364株 | +4% | 80,280株 | +153.63% | 312,165株 | +4.1% | 13,484株 | +140.79% |
2019/09/20 | 日証協 | 404,186株 | -0.69% | 31,652株 | -10.59% | 299,876株 | -0.86% | 5,600株 | -76.76% |
2019/09/13 | 日証協 | 406,986株 | -3.85% | 35,400株 | -38.32% | 302,476株 | -1.95% | 24,094株 | +381.88% |
※株式分割は考慮していませんのでご注意ください。
Page Top